This inventor holds 1 USPTO granted patent. Top assignee: Osteoneurogen Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Moon Kee Maeng in Anti-Inflammatory Research
Introduction
Moon Kee Maeng is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of anti-inflammatory research. His work focuses on developing compositions that can effectively inhibit inflammatory responses.
Latest Patents
Moon Kee Maeng holds 1 patent for an anti-inflammatory composition. This invention relates to a composition containing a specific compound that inhibits the interaction between CD14 and LPS. It also blocks the expression of CD14, TNFα, and IL-1β, which are key factors in the inflammatory response. The composition is designed to regulate the expression of important factors involved in inflammation, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP, and NOX1.
Career Highlights
Moon Kee Maeng is currently associated with Osteoneurogen Inc., where he continues to advance his research in the field of inflammation. His innovative approach has the potential to lead to new treatments for inflammatory diseases.
Collaborations
He collaborates with notable colleagues, including Byung Soo Youn and Han Soo Kim, who contribute to his research efforts.
Conclusion
Moon Kee Maeng's work in developing anti-inflammatory compositions showcases his dedication to innovation in medical research. His contributions may pave the way for new therapeutic strategies in managing inflammation.